TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study.

Jason J Luke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.